Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 14, 2015; 21(34): 10054-10056
Published online Sep 14, 2015. doi: 10.3748/wjg.v21.i34.10054
Published online Sep 14, 2015. doi: 10.3748/wjg.v21.i34.10054
Figure 1 Proportion of the de novo non-alcoholic fatty liver disease/control categorized by the body mass index-PNPLA3 I148M polymorphism.
BMI (+) represents BMI ≤ 25 kg/m2; BMI (-) represents BMI > 25 kg/m2; PNPLA3 (+) indicates PNPLA3 I148M GG carriers; PNPLA3 (-) indicates the PNPLA3 I148M CC + CG carriers. BMI: Body mass index; NAFLD: Non-alcoholic fatty liver disease.
- Citation: Liu ZT, Chen TC, Lu XX, Cheng J, Xie HY, Zhou L, Zheng SS. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients. World J Gastroenterol 2015; 21(34): 10054-10056
- URL: https://www.wjgnet.com/1007-9327/full/v21/i34/10054.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i34.10054